Roger D Cone
Tadataka Yamada Distinguished University Professor of Molecular and Integrative Physiology
Mary Sue Coleman Director of the Life Sciences Institute
Research Professor, Life Sciences Institute
Professor of Molecular, Cellular and Developmental Biology, College of Literature, Science, and the Arts
Professor of Molecular and Integrative Physiology, Medical School
[email protected]
Available to mentor
Roger D Cone
Director
Manage Your Profile
Center Memberships
-
Center MemberCaswell Diabetes Institute
Recent Publications
-
Buscaglia P, Bowman KR, Lawler K, Hernandez CC, Scotucci J, Bounds R, Keogh JM, Henning E, Cone RD, Farooqi IS, Sebag JA. 2026 Jan 19; medRxiv,PreprintAttractin-Like Protein 1 (ATRNL1): An Essential Partner of MC4R to Regulate Body Weight
DOI:10.64898/2026.01.12.26343722 -
Caruso V, Tatro JB, Schiöth H, Pouton C, Mountjoy KG, Hruby VJ, Haskell-Luevano C, Gantz I, Fong TM, Farooqi S, Eberle AN, Cone RD, Clark AJL, Chai B-X, Wikberg JES. IUPHAR/BPS Guide to Pharmacology CITE, 2025 Oct 20; 2025 (3):Journal ArticleMelanocortin receptors in GtoPdb v.2025.3
DOI:10.2218/gtopdb/f38/2025.3 -
Joy ST, Dahir NS, Cone RD, Mapp AK. Peptide Science, 2025 Jan 1; 117 (1):Journal ArticleAn Improved Synthesis of Compound 11, a Unique Bicyclic Melanocortin-3 Antagonist
DOI:10.1002/pep2.24385 -
Lu ZA, Ploner A, Birgegård A, Adan R, Alfredsson L, Ando T, Andreassen O, Baker J, Bergen A, Berrettini W, Boden J, Boehm I, Perica VB, Brandt H, Breen G, Bryois J, Buehren K, Bulik C, Burghardt R, Cassina M, Cichon S, Coleman J, Cone R, Courtet P, Crawford S, Crow S, Crowley J, Danner U, Davis O, De Zwaan M, Dedoussis G, Desocio J, Dick D, Dikeos D, Dina C, Dmitrzak-Weglarz M, Docampo E, Duncan L, Egberts K, Ehrlich S, Escaramís G, Esko T, Estivill X, Farmer A, Favaro A, Fernández-Aranda F, Fischer K, Föcker M, Foretova L, Forstner A, Forzan M, Franklin C, Gallinger S, Giegling I, Giusti-Rodríguez P, Gonidakis F, Gordon S, Gorwood P, Mayora MG, Grove J, Guillaume S, Guo Y, Hakonarson H, Halmi K, Hanscombe K, Hatzikotoulas K, Hauser J, Hebebrand J, Helder S, Herms S, Herpertz-Dahlmann B, Herzog W, Hinney A, Horwood LJ, Hübel C, Huckins L, Hudson J, Imgart H, Inoko H, Janout V, Jiménez-Murcia S, Johnson C, Jordan J, Julià A, Kalsi G, Kaminská D, Kaplan A, Kaprio J, Karhunen L, Karwautz A, Kas M, Kaye W, Kennedy J, Kennedy M, Keski-Rahkonen A, Kiezebrink K, Kim YR, Klareskog L, Klump K. Schizophrenia Bulletin, 2024 Sep 1; 50 (5): 1255 - 1265.Journal ArticleShared Genetic Architecture Between Schizophrenia and Anorexia Nervosa: A Cross-trait Genome-Wide Analysis
DOI:10.1093/schbul/sbae087 PMID: 38848516 -
Dahir NS, Gui Y, Wu Y, Sweeney PR, Rouault AAJ, Williams SY, Gimenez LE, Sawyer TK, Joy ST, Mapp AK, Cone RD. Journal of Clinical Investigation, 2024 Jul 15; 134 (14):Journal ArticleSubthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice
DOI:10.1172/JCI178250 PMID: 39007271 -
Li L, Hernandez CC, Gimenez LE, Xu B, Dahir NS, Swati , Birnbaum SG, Cone RD, Liu C. 2024 Jun 8;PreprintFunctional coupling between MC4R and Kir7.1 contributes to clozapine-induced hyperphagia.
DOI:10.1101/2024.06.07.597973 PMID: 38895206 -
Peisley A, Hernandez CC, Dahir NS, Koepping L, Raczkowski A, Su M, Ghamari-Langroudi M, Ji X, Gimenez LE, Cone RD. 2024 Jun 8;PreprintStructure of the Ion Channel Kir7.1 and Implications for its Function in Normal and Pathophysiologic States.
DOI:10.1101/2024.06.07.597981 PMID: 38895219 -
Gimenez LE, Martin C, Yu J, Hollanders C, Hernandez CC, Wu Y, Yao D, Han GW, Dahir NS, Wu L, Van der Poorten O, Lamouroux A, Mannes M, Zhao S, Tourwé D, Stevens RC, Cone RD, Ballet S. Journal of Medicinal Chemistry, 2024 Feb 22; 67 (4): 2690 - 2711.Journal ArticleNovel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design
DOI:10.1021/acs.jmedchem.3c01822 PMID: 38345933
Featured News & Stories
Health Lab
Protein targets can act as a switch for obesity and anorexia
In the U.S., dietary obesity has a prevalence of 40% and obesity increases the risk of other chronic diseases such as heart disease and diabetes. Even though anorexia nervosa has a prevalence of 1%, it is the second-highest death rate of any mental illness. Roger Cone discusses how melanocortin receptors can be used to treat both obesity and anorexia.
Health Lab
Diabetes and weight loss drugs could be enhanced, shows study in mice
A network of proteins found in the central nervous system could be harnessed to increase the effectiveness, and reduce the side effects, of diabetes and weight-loss drugs such as Ozempic and Mounjaro, according to research from the University of Michigan Life Sciences Institute.
Points of Blue
Katie Emery, PhD Candidate: Staying intentional in and out of the lab
Katie Emery is a PhD Candidate in the Neuroscience Graduate Program.